Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myasthenic Syndromes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07226726
What this trial is testing

Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution

Who this might be right for
Congenital Myasthenic Syndrome
The Foundation for Orthopaedics and Regenerative Medicine 20
Not applicableLooking for participantsNCT07478172
What this trial is testing

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Who this might be right for
Neuromuscular Diseases (NMD)Amyotrophic Lateral SclerosisMyasthenia Gravis+15 more
University of Missouri-Columbia 50
Not applicableApproved For MarketingNCT01825395
What this trial is testing

Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome

Who this might be right for
Lambert Eaton Myasthenic Syndrome
University of Colorado, Denver
Large-scale testing (Phase 3)Study completedNCT01377922
What this trial is testing

Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)

Who this might be right for
Lambert Eaton Myasthenic Syndrome
Catalyst Pharmaceuticals, Inc. 38
Testing effectiveness (Phase 2)Study completedNCT01511978
What this trial is testing

Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome

Who this might be right for
Lambert-Eaton Myasthenic SyndromeEaton-Lambert Myasthenic Syndrome
Jacobus Pharmaceutical 32
Large-scale testing (Phase 3)Study completedNCT02970162
What this trial is testing

Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)

Who this might be right for
Lambert-Eaton Myasthenic Syndrome
Catalyst Pharmaceuticals, Inc. 26
Not applicableStudy completedNCT05408702
What this trial is testing

Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes

Who this might be right for
Autoimmune Myasthenia GravisLambert-Eaton Myasthenic SyndromeCongenital Myasthenic Syndrome+1 more
Institut de Myologie, France 500
Testing effectiveness (Phase 2)UnknownNCT00541216
What this trial is testing

Ephedrine for the Treatment of Congenital Myasthenia

Who this might be right for
Myasthenic Syndromes, Congenital
Hadassah Medical Organization 15
Not applicableLooking for participantsNCT01403402
What this trial is testing

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

Who this might be right for
Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) DeficiencyAlpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy)Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Fatty Liver and Infantile-onset Cataract Caused by TRAPPC11 Mutations)+49 more
Cure CMD
Not applicableUnknownNCT02124616
What this trial is testing

National Registry for Egyptian Pediatric Neuromuscular Diseases

Who this might be right for
Spinal Muscular AtrophyMuscular DystrophyMuscle Diseases+2 more
Ain Shams University 200
Early research (Phase 1)Study completedNCT07105371
What this trial is testing

Patients With ALS and Other Motor Disorders Will be Treated With Mesenchymal Cell Exosome Solution

Who this might be right for
Motor Disorders
The Foundation for Orthopaedics and Regenerative Medicine 18
Early research (Phase 1)Active Not RecruitingNCT06436742
What this trial is testing

A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)

Who this might be right for
Congenital Myasthenic SyndromeCMS
argenx 15
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Not applicableStudy completedNCT00004832
What this trial is testing

Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome

Who this might be right for
Lambert-Eaton Myasthenic Syndrome
FDA Office of Orphan Products Development 26
Large-scale testing (Phase 3)Not Yet RecruitingNCT07746089
What this trial is testing

Assess Efficacy and Safety of Adimanebart in Adult and Pediatric Participants With DOK7-,MUSK-, AGRN-, or LRP4- Congenital Myasthenic Syndromes (CMS)

Who this might be right for
Congenital Myasthenic SyndromeCMS
argenx 105
Testing effectiveness (Phase 2)Ended earlyNCT02090725
What this trial is testing

Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS)

Who this might be right for
Muscle Weakness
Jeffrey A. Cohen, MD 4
Not applicableLooking for participantsNCT06078553
What this trial is testing

A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4

Who this might be right for
Congenital Myasthenic Syndrome
argenx 100
Not applicableNo Longer AvailableNCT00994916
What this trial is testing

Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine

Who this might be right for
Lambert-Eaton Myasthenic Syndrome
David Lacomis, MD
Not applicableStudy completedNCT01474980
What this trial is testing

Pregnancy Outcomes in Congenital Myasthenie Syndrome

Who this might be right for
Congenital Myasthenic Syndrome
Institut de Myologie, France 25
Early research (Phase 1)Study completedNCT01203592
What this trial is testing

Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes

Who this might be right for
Congenital Myasthenic Syndrome
Mayo Clinic 21
Next Page
4,000